ArticleJAMA ophthalmology2019

Month 12 Outcomes After Treatment Change at Month 6 Among Poor Responders to Aflibercept or Bevacizumab in Eyes With Macular Edema Secondary to Central or Hemiretinal Vein Occlusion: A Secondary Analysis of the SCORE2 Study.

Michael S Ip et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.